PHC GROUPPHC Holdings Corporation

  • About Us
  • Group Companies
  • Products & Services
  • CSR
  • Investor Relations

About Us

Corporate Overview History Our Culture Leadership

Group Companies

Ascensia Epredia PHCbi Medicom LSI Medience

Products & Services

Cancer Pathology Biologic & Cell Preservation Diagnostic Testing Patient Record & Billing Software Diabetes Management Medical Device & Drug Delivery

CSR

CORPORATE INTEGRITY

  • Code of Conduct
  • Corporate Governance
  • Risk Management
  • Information Security
  • CSR Procurement
  • Developing Quality Products
  • Customer Satisfaction

PEOPLE INSIGHTS

  • Human Rights Policy
  • Promoting Diversity
  • Work Style Reform
  • Developing Human Resources
  • Creating a Safe & Healthy Workplace

ENVIRONMENTAL SUSTAINABILITY

  • Environmental Activities

SOCIAL RESPONSIBILITY

  • Solving Problems through Business
  • Regional Social Action Programs
  • COVID-19 Response

Investor Relations

INVESTOR RELATIONS

MANAGEMENT

  • Corporate Governance
  • IR Basic Policy

IR LIBRARY

  • Financial Results
  • Presentation Materials
  • IR Materials

STOCK INFORMATION

  • Stock Overview
  • General Meeting of Shareholders
  • Stock Quotations
IR News Financial Highlights IR Calendar Contact IR Disclaimer
NewsroomCareersContact
JP

Other PHC Group Websites

  • PHC Corporation
  • Ascensia Diabetes Care
  • Epredia
  • LSI Medience Corporation
  • PT PHC Indonesia
  • PHC Corporation of North America
  • PHC Europe B.V.
  • PHC Medicom Corporation
  • PHC Corporation (Shanghai) Ltd.
  • SciMed(Asia)Pte Ltd
  • Amelieff Corporation

Other PHC Group Websites

  • PHC Corporation
  • Ascensia Diabetes Care
  • Epredia
  • LSI Medience Corporation
  • PT PHC Indonesia
  • PHC Corporation of North America
  • PHC Europe B.V.
  • PHC Medicom Corporation
  • PHC Corporation (Shanghai) Ltd.
  • SciMed(Asia)Pte Ltd
  • Amelieff Corporation
NewsroomCareersContactJP
Newsroom > 2022

News


2022

  • Select year

    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015

PHC Holdings Corporation

Group Companies

May.25IR
Notice regarding the Early Retirement Program at PHC Holdings Corporation and the consolidated subsidiaries
May.25News
Announcement of Changes to Board of Directors at PHC Holdings Corporation Effective June 29 and July 1
May.12IR
PHC Holdings Corporation Announces FY21 Full-Year Results and FY22 Forecast
Apr.28News
PHC Holdings Corporation Appoints Shoji Miyazaki as Chief Executive Officer
Apr.22News
Resignation of Independent External Director of PHC Holdings Corporation
Apr.4News
Resignation of Independent External Director of PHC Holdings Corporation
Jan.19News
Changes in Corporate Officer Areas of Responsibility at PHC Holdings Corporation Effective January 19, 2022
May.25PHCCorporate
Announcement of New Appointment of a Director at PHC Corporation Effective on June 27, 2022
May.2AscensiaProducts
Ascensia Diabetes Care Presents New Research Showing that People Using the CONTOUR® Blood Glucose Monitoring System and App Experience Fewer Out-of-Target Blood Glucose levels
Apr.18PHC IVDProducts
PHC Receives First EU-MDR Certification, Delivers Motorized Drug Injection Device Enabling More Efficient Patient-Friendly Treatment of Arthritis and Other Inflammatory Conditions
Apr.4AscensiaProducts
Ascensia Diabetes Care Launches the 6 Month Eversense® E3 Continuous Glucose Monitoring System in the U.S. with the New Eversense Pass Savings Program
Mar.1AscensiaProducts
Ascensia Diabetes Care Launches the Eversense® Now Remote Monitoring App for Android Users in Europe
Feb.14AscensiaProducts
Ascensia Diabetes Care Announces FDA Approval of the Eversense E3 Continuous Glucose Monitoring System for Use for Up to 6 Months
Feb.14AscensiaCorporate
Ascensia Diabetes Care Proudly Supports Spare a Rose Campaign for Fifth Consecutive Year
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
Terms of UsePrivacy PolicyFacebookLinkedIn © PHC Holdings Corporation All rights reserved.